Solidus Biosciences is a Troy, NY-based start up company developing the MetaChip. Quoting from a recent press release:
“Compounds can be screened early, quickly, and effectively by the MetaChip to prevent toxic drugs from getting through the discovery process, being put on the market, and then getting recalled, such as we’ve seen with several high-profile cases recently,” says JonathanThis is a very interesting area, and we're just at the tip of the iceberg of what is possible via miniaturization.
Dordick, the Howard P. Isermann ’42 Professor of Chemical and Biological Engineering at Rensselaer.
The publication in PNAS is here: Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses -- Lee et al., 10.1073/pnas.0406755102 -- Proceedings of the National Academy of Sciences
Comments